BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell
License Agreement Details: BioLineRx has entered into a license agreement with Ayrmid for its FDA-approved stem cell mobilization agent, motixafortide (Aphexda), granting exclusive rights for development and commercialization outside Asia, in exchange for a $10M upfront payment and potential additional earnings of up to $87M plus royalties.
Financial Impact and Future Plans: The agreement is expected to reduce BioLineRx's long-term debt and operational expenses, while also providing funding through a $9M equity investment from Highbridge Capital Management, allowing the company to advance its pipeline and continue developing motixafortide for pancreatic cancer.
Get Free Real-Time Notifications for Any Stock
Analyst Views on BLRX
About BLRX
About the author
Today's Options Volatility and Implied Earnings Changes - November 24, 2025
Earnings Reports Today: Major companies such as Agilent, Zoom Video Communications, and Semtech are set to report their earnings today, with expected significant stock movements based on options prices.
Options Activity Insights: Investors are closely monitoring options activity prior to earnings announcements, as it can provide insights into potential stock price movements following the reports.
Implied Moves Before Market Open: Companies like Bioline RX and Lexinfintech are expected to have substantial implied moves of +/- 187.69% and +/- 30.33%, respectively, before the market opens.
Implied Moves After Market Close: Other companies reporting after market close, including Agilent and Zoom, have implied moves ranging from +/- 8.20% to +/- 29.35%, indicating varying levels of expected volatility.
Options Volatility and Projected Earnings Changes for the Week of November 24 – November 26, 2025
Upcoming Earnings Reports: Major companies such as Alibaba, Nio, Zoom, Dell, and Li Auto are set to report their earnings this week.
Options Volatility: The article discusses how options volatility increases before earnings announcements due to uncertainty, leading to higher option premiums.
Volatility Crush: After earnings are announced, the uncertainty resolves, causing a significant decrease in option premiums, known as the volatility crush.
Expected Stock Moves: The expected stock price movements for various companies are provided, with percentages indicating potential volatility around their earnings announcements.